Bliss GVS Pharma Ltd share price logo

Bliss GVS Pharma Ltd

NSE: BLISSGVS

BSE: 506197

Small Cap

Healthcare Sector

₹257.42

-3.56

(-1.36%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Bliss GVS Stock Performance

as on April 15, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹256.25
    ₹267.50
    downward going graph

    0.45%

    Downside

    3.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹109.03
    ₹267.50
    downward going graph

    57.65%

    Downside

    3.92%

    Upside

    downward going graph

Bliss GVS share price movements today

Previous Close
₹260.98
Open
₹265.00
Volume
11.23L
Upper Circuit
₹313.17
Lower Circuit
₹208.79
Day's Low - High
₹256.25 - ₹267.50
52 Week Low - High
₹109.03 - ₹267.50

Bliss GVS Historical Returns

1 Month Return
+ 29.1 %
3 Month Return
+ 51.65 %
1 Year Return
+ 109.45 %
3 Year Return
+ 253.15 %
5 Year Return
+ 172.28 %

Bliss GVS Fundamentals

as on April 15, 2026 at 4:01 pm IST

Market Cap

₹2,760.88 Cr

Return on Equity (ROE)

6.74

PE Ratio (TTM)

25.26

Return on capital employed (ROCE)

9.16

Industry PE ratio

41.39

Beta (LTM)

1.49

P/B Ratio

1.17

Dividend Yield

0.43

PEG Ratio

5.42

Quarterly Earnings Growth YOY

-3.95

EPS (TTM)

8.57

Sector

Pharmaceuticals

Book Value

99.68

Technical Analysis

Bullish

View Technical Analysis

Bliss GVS Stock Valuation

as on April 15, 2026 at 4:01 pm IST

Bliss GVS in the last 5 years

  • Overview

  • Trends

Lowest (7.08x)

August 22, 2019

Today (25.26x)

April 13, 2026

Industry (41.39x)

April 13, 2026

Highest (576.11x)

January 3, 2022

LowHigh

Today’s Price to Earnings Ratio: 25.26x

Bliss GVS Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bliss GVS with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Bliss GVS Pharma Ltd image
Bliss GVS Pharma Ltd
NA2,760.8834.46%0.5690809
Alembic Pharmaceuticals Ltd image
Alembic Pharmaceuticals Ltd
BUY14,103.40-5.25%0.615826,672
Ishita Drugs & Industries Ltd image
Ishita Drugs & Industries Ltd
NA24.0531.9%0.00NA15
Vivimed Labs Ltd image
Vivimed Labs Ltd
NA60.61-11.4%1.02-32116
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY13,718.86-5.26%0.682641,197
See all

Bliss GVS Stock’s Investor Sentiment and Interest

Search interest for Bliss GVS Pharma Ltd Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-12% versus previous 30 day period

Bliss GVS Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
159.52
211.88
200.72
198.13
183.64
217.68
210.42
197.99
207.47
244.4
218.25
Other Income
5.11
12.6
5.42
5.6
4.12
5.04
15.27
12.07
35.45
8.46
18.46
Total Income
164.63
224.48
206.14
203.73
187.77
222.72
225.68
210.05
242.92
252.86
236.71
Expenses
135.31
157.51
157.02
198.98
149.31
176.2
180.63
176.9
166.14
200.92
185.98
Operating Profit
24.21
54.37
43.7
-0.85
34.33
41.48
29.79
21.09
41.33
43.48
32.27
Operating Profit Margin %
15.18%
25.66%
21.77%
-0.43%
18.69%
19.06%
14.16%
10.65%
19.92%
17.79%
14.79%
Profit Before Interest, Tax and Depreciation
29.33
66.97
49.12
4.75
38.45
46.51
45.05
33.15
76.78
51.94
50.73
Interest
1.49
1.45
2.12
1.85
1.53
3.83
1.08
1.68
5.47
3.04
1.49
Depreciation
6.19
6.39
6.95
6.85
6.85
6.98
7.55
8.04
8.2
8.26
8.35
Profit Before Tax
21.65
59.13
40.05
-3.95
30.07
35.7
36.42
23.43
63.11
40.64
40.89
Tax Paid
7.28
16.08
10.97
0.96
7.96
10.01
10.62
6.79
18.74
12.04
16.12
Profit After Tax
14.37
43.04
29.07
-4.91
22.11
25.69
25.8
16.65
44.36
28.59
24.78
Total Net profit including share of profit / Loss from associate company
14.37
43.04
29.07
-4.91
22.11
25.69
25.8
16.65
44.36
28.59
24.78
EPS
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
2.2
Actual EPS
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
2.2
Adjusted EPS
1.41
4.06
2.64
-0.88
1.97
2.31
2.27
1.47
4.08
2.58
2.2
Diluted EPS
1.41
3.98
2.6
-0.86
1.93
2.29
2.27
1.46
4.04
2.54
2.14

Bliss GVS Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
814.64
898.57
689.31
577.21
747.45
751.59
770.24
809.73
Other Income
26.54
37.63
39.19
20.22
31.49
17.79
28.74
36.49
Total Income
841.18
936.2
728.49
597.43
778.95
769.37
798.98
846.22
Expenses
651.7
740.93
579.37
470.56
702.71
634.27
648.82
683.04
Operating Profit
162.94
157.64
109.94
106.65
44.74
117.32
121.42
126.69
Operating Profit Margin %
20%
17.54%
15.95%
18.48%
5.99%
15.61%
15.76%
15.65%
Profit Before Interest, Tax and Depreciation
189.48
195.27
149.12
126.87
76.24
135.11
150.16
163.18
Interest
22.8
4.41
7.57
5.51
4.74
10.36
6.91
8.12
Depreciation
21.38
8.94
12.59
17.23
17.33
18.67
26.38
29.42
Profit Before Tax
145.3
181.92
128.96
104.13
54.17
106.08
116.87
125.64
Tax Paid
56.63
55.25
33.72
30.15
31.04
29.33
35.29
35.39
Profit After Tax
88.67
126.66
95.25
73.97
23.13
76.73
81.58
90.26
Total Net profit including share of profit / Loss from associate company
88.67
126.66
95.25
73.97
23.13
76.73
81.58
90.26
EPS
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
Actual EPS
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
Adjusted EPS
5.7
11.99
9.43
6.64
1.46
6.83
7.23
8.02
Diluted EPS
5.7
11.99
9.43
6.49
1.43
6.72
7.11
7.95

Bliss GVS Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
112.95
289.47
17.64
39.95
46.7
63.97
135.48
34.31
102.82
105.91
Cash Flow from Investing Activities
-51.55
-249.23
47.87
-78.7
-40.09
-45.37
-102.89
-6.36
-83.34
-75.34
Cash Flow from Financing Activities
-40.25
-10.13
-75.98
16.83
-6.3
-20.79
-23.73
-24.95
-20.88
-30.35
Net Cash Flow
22.51
30.11
-10.46
-21.91
0.3
-2.21
8.85
3.02
-1.42
0.23

Bliss GVS Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
35.12%
35.06%
34.97%
34.97%
34.9%
34.82%
35.1%
35.29%
35.44%
35.39%
35.36%
DII
6.62%
6.61%
6.59%
6.59%
6.58%
6.57%
6.55%
6.55%
6.54%
5.98%
5.78%
FII
0%
16.31%
0%
14.73%
13.25%
12.13%
13.51%
13.18%
12.65%
13.27%
14.54%
Public
41.75%
42.01%
43.08%
43.71%
45.27%
46.49%
44.84%
44.98%
45.36%
45.36%
44.32%
Total Outstanding Shares
10,42,23,172
10,43,98,672
10,46,90,822
10,46,90,822
10,48,82,572
10,51,44,472
10,53,66,272
10,53,70,272
10,54,97,522
10,56,49,472
10,57,88,972
Total Shareholders
42,182
43,234
40,758
45,157
44,737
52,937
49,558
49,517
46,707
44,461
43,380

Mutual Funds that own Bliss GVS Stock

Check out the Mutual Funds with significant holdings in Bliss GVS.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.11%
799

Bliss GVS Corporate Actions

View detailed summary of the earnings and dividend history of Bliss GVS.

  • Bliss GVS Pharma Ltd Earnings Results

    Bliss GVS Pharma Ltd’s net profit fell -2.23% since last year same period to ₹23.27Cr in the Q3 2025-2026. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -14.61% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Bliss GVS Pharma Ltd Dividends February,2026

    In the quarter ending December 2025, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 per share on 10 Feb 2026 - translating a dividend yield of 0.38%.

    Read More about Dividends

Indices Featuring Bliss GVS Stock

Check stock indices that include Bliss GVS.

BSE Healthcare

₹43,234.07

1.71 (▲726.14%)

Insights on Bliss GVS Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 13.27% to 14.54% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BLISSGVS stock has moved up by 29.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 43.04 Cr → 23.27 Cr (in ₹), with an average decrease of 25.7% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 35.39% to 35.36% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 45.36% to 44.32% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 252.86 Cr → 236.71 Cr (in ₹), with an average decrease of 6.4% per quarter

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd is an export-oriented pharmaceutical company providing products in the antimalarial, antifungal, antibacterial, anti-inflammatory, and antibiotic segments. Boasting one of the largest portfolios of Suppositories and Pessaries dosage forms, the leading company is the only EUGMP certified suppositories manufacturer in India, and has a research and development centre with over 50 scientists certified by the Department of Scientific and Industrial Research.

Bliss GVS Pharma has a successful history, with various achievements over the years, such as investment in 51 share capital of Lifeon Labs Pvt Ltd. and the formation of a new company, Asterisk Lifesciences Limited, as a wholly owned foreign subsidiary in the UK for registrations and marketing in Europe. The company has also procured a USD 111.40 million contract from Aon.

To further its growth, Bliss GVS Pharma divested three subsidiaries and one stepdown subsidiary in 2018. The company also invested in a new 200,000 sq. ft. multiproduct facility in Maharashtra, equipped with state-of-the-art process equipment and utilities. In the financial year 2019-2020, the company had 4 wholly owned subsidiaries and 3 stepdown subsidiaries.

Revenue: ₹218.25Cr as on December 2025 (Q3 FY26)
Net Profit: ₹24.78Cr as on December 2025 (Q3 FY26)
Listing date: 26 Jul, 2010
Chairperson Name: Subramanian R Vaidya
OrganisationBliss GVS Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOSubramanian R Vaidya
E-voting on sharesClick here to vote

FAQs

What is Bliss GVS share price today?

Bliss GVS share price today stands at ₹257.42 as on at the close of the market. Bliss GVS share today touched a day high of ₹267.5 and a low of ₹256.25.

What is the 52 week high and 52 week low range for Bliss GVS share?

Bliss GVS touched a 52 week high of ₹267.5 and a 52 week low of ₹109.03. Bliss GVS share price today i.e. is closed at ₹257.42, which is -3.77% down from its 52 week high and 136.10% up from its 52 week low.

What is Bliss GVS's market capitalisation today?

Bliss GVS market capitalisation is ₹2,760.88 Cr as on .

How to buy Bliss GVS shares?

To buy Bliss GVS shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BLISSGVS or Bliss GVS Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Bliss GVS shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Bliss GVS trading volume today?

Bliss GVS trading volume is 11.23L as on . This means that 11.23L shares of Bliss GVS were bought and sold on the stock market during today's trading session.